WallStSmart

F5 Networks Inc (FFIV)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

F5 Networks Inc generates 1114% more annual revenue ($3.14B vs $258.90M). FFIV leads profitability with a 22.5% profit margin vs -15.5%. FFIV earns a higher WallStSmart Score of 63/100 (C+).

FFIV

Buy

63

out of 100

Grade: C+

Growth: 5.3Profit: 8.5Value: 4.7Quality: 7.5
Piotroski: 5/9Altman Z: 2.65

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

FFIVOvervalued (-8.8%)

Margin of Safety

-8.8%

Fair Value

$259.69

Current Price

$328.15

$68.46 premium

UndervaluedFair: $259.69Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FFIV4 strengths · Avg: 8.8/10
Return on EquityProfitability
20.8%9/10

Every $100 of equity generates 21 in profit

Profit MarginProfitability
22.5%9/10

Keeps 23 of every $100 in revenue as profit

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

Operating MarginProfitability
26.0%8/10

Strong operational efficiency at 26.0%

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

FFIV2 concerns · Avg: 4.0/10
PEG RatioValuation
2.014/10

Expensive relative to growth rate

P/E RatioValuation
27.0x4/10

Moderate valuation

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : FFIV

The strongest argument for FFIV centers on Return on Equity, Profit Margin, Debt/Equity. Profitability is solid with margins at 22.5% and operating margin at 26.0%.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : FFIV

The primary concerns for FFIV are PEG Ratio, P/E Ratio.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

FFIV profiles as a mature stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

FFIV scores higher overall (63/100 vs 41/100), backed by strong 22.5% margins. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

F5 Networks Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

F5, Inc. is an American company that specializes in application delivery networking (ADN), application availability & performance, multi-cloud management, application security, network security, access & authorization and online fraud prevention. F5 is headquartered in Seattle, Washington, with additional development, manufacturing, and administrative offices worldwide.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?